Picture of Sichuan Kelun-Biotech Biopharmaceutical logo

6990 — Sichuan Kelun-Biotech Biopharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Kelun-Biotech And Crescent Biopharma Announce Strategic Partnership

Dec 4 (Reuters) -

KELUN-BIOTECH AND CRESCENT BIOPHARMA ANNOUNCE STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE NOVEL ONCOLOGY THERAPEUTICS

CRESCENT BIOPHARMA INC - CR-001 AND SKB105 TO ENTER PHASE 1/2 TRIALS IN Q1 2026

CRESCENT BIOPHARMA INC - KELUN-BIOTECH TO RECEIVE $80 MILLION UPFRONT PAYMENT,ADDITIONAL MILESTONES OF UP TO US$1.25 BILLION FROM CRESCENT

CRESCENT BIOPHARMA INC - CO TO RECEIVE $20 MILLION UPFRONT PAYMENT,ADDITIONAL MILESTONES OF UP TO US$30 MILLION FROM KELUN-BIOTECH

CRESCENT BIOPHARMA INC - KELUN-BIOTECH ELIGIBLE FOR MILESTONES UP TO $1.25 BILLION

Source text: ID:nGNXc0Mj7V

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sichuan Kelun-Biotech Biopharmaceutical

See all news